GENTAUR EUROPE  +32 1658 9045 +32 1650 9045BELGIUM1 tel +32 2 732 5688 fax +32 2 732 4414 [email protected] Av. de l' Armée 68 B-1040 Brussels France tel 01 43 25 01 50 fax 01 43 25 01 60 9, rue Lagrange 75005 Paris Italy tel 02 36 00 65 93 fax +32 16 50 90 45 20135 Milano Germany tel +32 16 58 90 45 fax +32 16 50 90 45 Forckenbeckstraße 6 D-52074 Aachen Japan tel +81 78 386 0860 fax +81 78 306 0296 Minaatojimaminami-manchi Chuo-ku, Kobe 065-0047  |
9. Duval, H. et al, (2003)'New insights into the function and regulation of endothelial cell apoptosis' Angiogenesis 6; 171-183
10. Shalhoub, J. et al, 2003 'Anti-angiogenic activity of heparins and anti-thrombin' J. Thromb. Haemostasis 1; Suppl 1 Abstract P0846
11. Numasaki, M. et al, (2003) 'Interleukin-17 promotes angiogenesis and tumour growth' Blood 101; 2620-2627
12. Burns, P.A. & Wilson, D.J., (2003) 'Angiogenesis mediated by metabolites is dependent on VEGF' Angiogenesis 6; 23-77
13. Shalhoub, J. et al, (2003) 'Anti-angiogenic activity of heparins and antithrombin J. Thromb. Haemostasis 1 Suppl July, P0846
14. Sengupta, S. et al (2003) 'Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms' Brit. J. Pharmacol. 139; 219-231
15. Oshima, Y. et al, (2003) 'Expression and localisation of tenomodulin, a transmembrane type chondomodulin-I-related angiogenesis inhibitor, in mouse eyes'. Invest. Ophthalmol. Vis. Sci. 44; 1814-1823
16. Igagarishi, T. et al (2003) 'Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularisation in a murine proliferative retinopathy model'. Gene Therapy 10; 219-226
17. Rossig, L., et al, (2002) "Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation & angiogenesis" Circulation Research 91, 837-851
18. Gliki, G. et al, (2002) ‘Vascular endothelial growth factor induces protein kinase c (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3’-kinase-mediated PKCd phosphorylation: Role of PKC in angiogenesis’ Cell Biology International 26; 751-759
19. Brooks, T. et al, Proc. AACR 43; 137 (2002)
20. Drinkwater, S.L., et al, (2002) ‘Effect of venous ulcer exudates on angiogenesis in vitro’ Brit. J. Surg. 89; 709-713
21. Urbich, C. et al. (2002) 'Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogeneic effects of endostatin'. FASEB J. express article 10.1096/fj.01-0637fje.
22. Urbich, C. et al. (2002) 'Double-Edged Role of Statins in Angiogenesis Signalling' Circulation Research. 90: 737-744.
23. Osugi, T. et al (2002) 'Cardiac-specific activation of Signal Transducer and Activator of Transcription-3 promotes vascular formation in the heart'J. Biol. Chem. 227; 6676-6681
24. Kronenwett, R. et al, (2002) 'Inhibition of angiogenesis in vitro by aV integrin-directed antisense oligonucleotides'.Cancer Gene Therapy 9; 587-596
25. Dredge, K. et al (2002) 'Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects'. Brit. J. Cancer 87; 1166-1172
26. Urbich et al (2002) 'CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species' Circulation, 106; 981-986
27. Svensson, L.A. et al (2002) 'The cytolethal distending toxin of Haemophilus ducreyi inhibits endothelial cell proliferation' Infection & Immunity 70; 2665-2669
28. Iba, O. et al, (2002) "Angiogenesis by implantation of peripheral blood mononuclear cells into ischaemic limbs" Circulation 106: 2019
29. Harmey, J.H. et al, (2002)'Lipoylsaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumour invasion' Int. J. Cancer 101; 415-422
30. Terai, Y. et al, (2001) 'Vascular smooth muscle cell growth promoting factor / F-spondin inhibits angiogenesis via the blockade of integrin aVb3 on vascular endothelial cells. J. Cell. Physiol. 188; 394-402
31. Ohno-Matsui, K. et al, (2001) 'Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF' J. Cell. Physiol. 189; 323-333
32. Jia, H. et al, (2001) ‘Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF’Biochem. Biophys. Res. Commun. 283; 164-173
33. Murphy, J.E. & Fitzgerald, D.J., (2001) ‘Vascular endothelial growth factor induces cyclooxygenase-dependent proliferation of endothelial cells via the VEGF-2 receptor’. FASEB J. 15; 1667-1
34. Houston, P. et al, (2001) ‘The transcriptional co-repressor NAB2 blocks Egr-1-mediated growth factor activation and angiogenesis’ Biochem. Biophys. Res. Commun. 283; 480-486
35. Bussolati, B. et al, (2001) ‘Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide’ Am. J. Path. 159; 993-1008
36. Frandsen, T. et al, Clin. Cancer Res. 7; Suppl. (2001)
37. Donovan et al, (2001) ‘Comparison of three in vitro human ‘angiogenesis’ assays with capillaries formed in vivo’ Angiogenesis 4; 113-121
38. Bryant, et al , (2000)‘Tissue repair with a therapeutic transcription factor’
Human Gene Therapy 11; 2143-2158
39. Bishop, E.T. et al, (2000) ‘An in vitro model of angiogenesis: Basic features Angiogenesis 3; (4); 335-344
40. Brooks, T.D. et al, (1999) ‘Antibodies to PAI-1 suppress angiogenesis in vitro’Clin. Exp. Metastasis 17 (9); 112
41. Grohmann, M et al, (1999)‘Nitric oxide released via VEGFR-1 suppresses VEGFR-2 mediated endothelial cell growth and regulates angiogenesis’J. Reprod. Fertil. (Abs Series 24) No 48
TCS AngioKit: CD31 stained tubule formation
